Dare Bioscience (DARE) Misses Q3 EPS by 55c

Dare Bioscience (NASDAQ: DARE) reported Q3 EPS of ($0.55). Revenue for the quarter came in at $41.69 million.

For earnings history and earnings-related data on Dare Bioscience (DARE) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Baldwin Insurance (BWIN) call put ratio 5.9 calls to 1 put with a focus on July 20 and 22.50 calls
• Jefferies explains Alphabet (GOOGL) selloff: 1. Exec departures 2. Mag7 softness ahead of AI IPOs 3. Multiple normalization